by Jordana Choucair | Feb 7, 2023 | D.C. News
President Joe Biden will deliver his second State of the Union address this evening. During the speech, he will ask for insulin cost caps for privately insured patients and a renewed bid to close the Medicaid coverage gap in Republican-controlled states that...
by Jordana Choucair | Feb 7, 2023 | Health IT
A bipartisan group of senators requested that three telehealth providers provide a list of all third-party platforms they’ve shared user information with over the past three years, along with details about what types of user information they shared. The letters – sent...
by Jordana Choucair | Feb 7, 2023 | Life Sciences
Senate Finance Committee Chairman Ron Wyden vowed that Democrats intend to protect Medicare drug price negotiation measures passed last year as part of the Inflation Reduction Act and that the pharmaceutical industry is targeting. Wyden said during an event that...
by Jordana Choucair | Feb 7, 2023 | M&A
CVS Health is closing in on a deal to acquire Medicare-focused primary care company Oak Street Health for about $10.5 billion including debt. Per the Wall Street Journal, if the companies agree to the terms, the deal could be announced as soon as this week. Oak Street...
by Jordana Choucair | Feb 7, 2023 | Providers
The U.S. District Court for the Eastern District of Texas ruled in favor of the Texas Medical Association’s (TMA) motion for summary judgment in its lawsuit opposing certain components of the surprise billing rule. The TMA filed this lawsuit in September alleging the...
by Jordana Choucair | Feb 6, 2023 | Life Sciences
A Wall Street Journal article examines how Amazon’s new RxPass prescription service and Mark Cuban’s Cost Plus Drug Co. are increasing the downward pressure on the cost of generic drugs. The competition from both entities has instigated more established players...
Recent Comments